Posts Tagged ‘patent expiration’

Drug Patent Expirations for the Week of January 15, 2023

LATISSE (bimatoprost) Allergan Patent: 8,758,733 Expiration: Jan 15, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…


New patent expiration for Kyowa Kirin drug NOURIANZ

Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Kyowa Kirin drug NOURIANZ appeared first on…


Biotechblog